Invesco Ltd. Acquires 87,215 Shares of STERIS plc (NYSE:STE)

Invesco Ltd. boosted its stake in shares of STERIS plc (NYSE:STE - Free Report) by 9.3% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 1,022,479 shares of the medical equipment provider's stock after purchasing an additional 87,215 shares during the period. Invesco Ltd. owned approximately 1.04% of STERIS worth $210,181,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the stock. Avalon Trust Co acquired a new stake in STERIS in the 4th quarter valued at $30,000. Human Investing LLC acquired a new stake in shares of STERIS in the fourth quarter valued at about $31,000. Anfield Capital Management LLC boosted its position in STERIS by 100.0% during the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock worth $37,000 after acquiring an additional 91 shares during the last quarter. Central Pacific Bank Trust Division raised its holdings in STERIS by 65.5% in the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock valued at $39,000 after acquiring an additional 76 shares during the last quarter. Finally, Manchester Capital Management LLC grew its position in shares of STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock valued at $44,000 after purchasing an additional 137 shares in the last quarter. Hedge funds and other institutional investors own 94.69% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. Needham & Company LLC reaffirmed a "hold" rating on shares of STERIS in a research note on Monday, April 7th. Stephens restated an "overweight" rating and issued a $240.00 price objective on shares of STERIS in a report on Thursday, February 6th. JMP Securities reiterated a "market outperform" rating and issued a $265.00 target price on shares of STERIS in a report on Thursday, April 10th. Finally, Piper Sandler increased their price objective on shares of STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $258.75.

Remove Ads

STERIS Stock Down 0.4 %

STE traded down $0.82 on Wednesday, reaching $220.22. The company's stock had a trading volume of 358,570 shares, compared to its average volume of 531,972. STERIS plc has a 1 year low of $197.82 and a 1 year high of $248.24. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. The stock has a market cap of $21.64 billion, a price-to-earnings ratio of 46.76 and a beta of 0.87. The business's 50 day moving average is $222.59 and its 200 day moving average is $219.41.

STERIS (NYSE:STE - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, research analysts forecast that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Stockholders of record on Thursday, February 20th were given a $0.57 dividend. The ex-dividend date of this dividend was Thursday, February 20th. This represents a $2.28 annualized dividend and a dividend yield of 1.04%. STERIS's dividend payout ratio is 48.41%.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.